Syntrix Presents at the 2009 NCI SBIR Investor Forum in Boston
Syntrix was one of 14 breakthrough technology companies invited to present at the 2009 SBIR Investor Forum sponsored by the National Cancer Institute (NCI). The chosen companies were selected from a highly competitive field of applicants by an independent panel of experts from venture capital firms, bio-pharmaceutical and medical device companies, based on their strength of research, impact on cancer, product development, and market potential. The Syntrix presentation featured L/D-aminopterin.
Read the event program book.
Read about L/D-aminopterin in our pipeline.